Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Checkmate Raises $27M to Develop Drug that Aids Cancer Checkpoint Inhibition

Checkmate Pharmaceuticals raised $27 million in a Series B preferred financing round to fund continued development of its early-clinical-stage ...

Forward this item to a colleague:


(Separate multiple addresses by commas)